174 related articles for article (PubMed ID: 18926687)
1. Identification of a novel agonist of peroxisome proliferator-activated receptors alpha and gamma that may contribute to the anti-diabetic activity of guggulipid in Lep(ob)/Lep(ob) mice.
Cornick CL; Strongitharm BH; Sassano G; Rawlins C; Mayes AE; Joseph AN; O'Dowd J; Stocker C; Wargent E; Cawthorne MA; Brown AL; Arch JR
J Nutr Biochem; 2009 Oct; 20(10):806-15. PubMed ID: 18926687
[TBL] [Abstract][Full Text] [Related]
2. P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.
Chen W; Zhou XB; Liu HY; Xu C; Wang LL; Li S
Br J Pharmacol; 2009 Jul; 157(5):724-35. PubMed ID: 19422369
[TBL] [Abstract][Full Text] [Related]
3. Korean Chungtaejeon tea extract attenuates body weight gain in C57BL/6J-Lep ob/ob mice and regulates adipogenesis and lipolysis in 3T3-L1 adipocytes.
Sharma BR; Kim DW; Rhyu DY
J Integr Med; 2017 Jan; 15(1):56-63. PubMed ID: 28088260
[TBL] [Abstract][Full Text] [Related]
4. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ
Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
[TBL] [Abstract][Full Text] [Related]
6. Cevoglitazar, a novel peroxisome proliferator-activated receptor-alpha/gamma dual agonist, potently reduces food intake and body weight in obese mice and cynomolgus monkeys.
Chen H; Dardik B; Qiu L; Ren X; Caplan SL; Burkey B; Boettcher BR; Gromada J
Endocrinology; 2010 Jul; 151(7):3115-24. PubMed ID: 20484464
[TBL] [Abstract][Full Text] [Related]
7. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
Massaro M; Scoditti E; Pellegrino M; Carluccio MA; Calabriso N; Wabitsch M; Storelli C; Wright M; De Caterina R
Pharmacol Res; 2016 May; 107():125-136. PubMed ID: 26976796
[TBL] [Abstract][Full Text] [Related]
9. Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor alpha/gamma agonist on glucose uptake.
Hu X; Feng Y; Liu X; Zhao XF; Yu JH; Yang YS; Sydow-Bäckman M; Hörling J; Zierath JR; Leng Y
Diabetologia; 2007 May; 50(5):1048-57. PubMed ID: 17333104
[TBL] [Abstract][Full Text] [Related]
10. PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects.
Kim MK; Chae YN; Choi SH; Moon HS; Son MH; Bae MH; Choi HH; Hur Y; Kim E; Park YH; Park CS; Kim JG; Lim JI; Shin CY
Eur J Pharmacol; 2011 Jan; 650(2-3):673-81. PubMed ID: 20974124
[TBL] [Abstract][Full Text] [Related]
11. Lipolytic and antiadipogenic effects of (3,3-dimethylallyl) halfordinol on 3T3-L1 adipocytes and high fat and fructose diet induced obese C57/BL6J mice.
Saravanan M; Pandikumar P; Saravanan S; Toppo E; Pazhanivel N; Ignacimuthu S
Eur J Pharmacol; 2014 Oct; 740():714-21. PubMed ID: 24952133
[TBL] [Abstract][Full Text] [Related]
12. The appetite regulatory effect of guggulsterones in rats: a repertoire of plasma hormones and neurotransmitters.
Mithila MV; Khanum F
J Diet Suppl; 2014 Sep; 11(3):262-71. PubMed ID: 25025986
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic effect of SN158 through PPARα/γ dual activation in ob/ob mice.
Jung Y; Cao Y; Paudel S; Yoon G; Cheon SH; Bae GU; Jin LT; Kim YK; Kim SN
Chem Biol Interact; 2017 Apr; 268():24-30. PubMed ID: 28242381
[TBL] [Abstract][Full Text] [Related]
14. Triterpenoids from Hibiscus sabdariffa L. with PPARδ/γ Dual Agonist Action: In Vivo, In Vitro and In Silico Studies.
Giacoman-Martínez A; Alarcón-Aguilar FJ; Zamilpa A; Hidalgo-Figueroa S; Navarrete-Vázquez G; García-Macedo R; Román-Ramos R; Almanza-Pérez JC
Planta Med; 2019 Mar; 85(5):412-423. PubMed ID: 30650453
[No Abstract] [Full Text] [Related]
15. Defatted safflower seed extract inhibits adipogenesis in 3T3-L1 preadipocytes and improves lipid profiles in C57BL/6J ob/ob mice fed a high-fat diet.
Hwang EY; Yu MH; Jung YS; Lee SP; Shon JH; Lee SO
Nutr Res; 2016 Sep; 36(9):995-1003. PubMed ID: 27632920
[TBL] [Abstract][Full Text] [Related]
16. Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.
Allen T; Zhang F; Moodie SA; Clemens LE; Smith A; Gregoire F; Bell A; Muscat GE; Gustafson TA
Diabetes; 2006 Sep; 55(9):2523-33. PubMed ID: 16936200
[TBL] [Abstract][Full Text] [Related]
17. C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.
Xu C; Wang LL; Liu HY; Zhou XB; Cao YL; Li S
Acta Pharmacol Sin; 2006 Feb; 27(2):223-8. PubMed ID: 16412273
[TBL] [Abstract][Full Text] [Related]
18. A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice.
Ngala RA; Stocker CJ; Roy AG; Hislop D; Wargent E; Bell R; Hassall DG; Harling JD; Billin AN; Willson TM; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2011 May; 13(5):455-64. PubMed ID: 21272187
[TBL] [Abstract][Full Text] [Related]
19. Leptin Production by Encapsulated Adipocytes Increases Brown Fat, Decreases Resistin, and Improves Glucose Intolerance in Obese Mice.
DiSilvestro DJ; Melgar-Bermudez E; Yasmeen R; Fadda P; Lee LJ; Kalyanasundaram A; Gilor CL; Ziouzenkova O
PLoS One; 2016; 11(4):e0153198. PubMed ID: 27055280
[TBL] [Abstract][Full Text] [Related]
20. Anti-diabetic properties of Daphniphyllum macropodum fruit and its active compound.
Koo HJ; Kwak JH; Kang SC
Biosci Biotechnol Biochem; 2014; 78(8):1392-401. PubMed ID: 25130743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
